Novo Nordisk A/S (NVO)

NVO trades at $59.64, 2.8% above the near-term max pain of $58 expiring Oct 10, 2025 (5 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($30-$62.5), indicating stable market expectations. Key magnetic zone at 55 where 7 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for NVO shows stable levels around 54.28, reflecting balanced market expectations. The 60% spread signals divergent expectations across timeframes. Most levels below 59.64 may cap rallies. Strong magnetic level at 55 (7 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.